Dapagliflozin in patients with cardiometabolic risk factors hospitalised with COVID-19 (DARE-19): a randomised, double-blind, placebo-controlled, phase 3 trial
The Lancet Diabetes & Endocrinology Vol 9: 586–594
Kosiborod M, Esterline R, Furtado M, Oscarsson J, Gasparyan S, Koch G and others
doi.org/10.1016/S2213-8587(21)00180-7
Screening for Prediabetes and Type 2 Diabetes US Preventive Services Task Force Recommendation Statement US Preventive Services Task Force
JAMA. 2021;326(8):736-743
doi.org/10.1001/jama.2021.12531
Long-Term Complications in Youth-Onset Type 2 DiabetesTODAY Study Group
N Engl J Med 2021;385:416-26.
hrrtps://doi.org/10.1056/NEJMoa2100165
Adult-onset autoimmune diabetes identified by glutamic acid decarboxylase autoantibodies: a retrospective cohort study.Wada E, Onoue T, Kinoshita T, Hayase A, Handa T, Ito M et al
Diabetologia
https://doi.org/10.1007/s00125-021-05516-1
Liver-targeting drugs and their effect on blood glucose and hepatic lipids
Gastaldelli A, Stefan N, Häring H
Diabetologia 2021 may: 64:1461–1479
https://doi.org/10.1007/s00125-021-05442-2
Frequency of Interruptions to Sitting Time: Benefits for Postprandial Metabolism in Type 2 Diabetes
Homer A, Taylor F, Dempsey P et al
Diabetes Care 2021 Jun; 44 (6): 1254-1263
https://doi.org/10.2337/dc20-1410
Comentarios recientes